Cov-MS peptide standard
Peptide standard for mass spectrometry detection and absolute quantification of SARS-CoV-2 proteins co-developed by PolyQuant and University of Ghent (Bart Van Puyvelde, Maarten Dhaenens, et al., 2020: Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients).
|Order Number||Product description|
|PQ-CS-2500||SARS-CoV-2 15N-labeled MS Standard, complete protein||show package sizes and pricing information|
|PQ-CS-2510||SARS-CoV-2 15N-labeled MS Standard, peptide mix||show package sizes and pricing information|
|PQ-CS-2520||SARS-CoV-2 unlabeled MS Standard, complete protein||show package sizes and pricing information|
|PQ-CS-2530||SARS-CoV-2 unlabeled MS Standard, peptide mix||show package sizes and pricing information|
To place your order, please contact us directly through:
Phone: +49 (0)9405 96999 10
Or Fax: +49 (0)9405 96999 28
PQ-Cov-MS peptide standard is based on PolyQuant’s proprietary QconCAT technology providing 17 validated peptides as heavy isotope labelled or as unlabelled artificial protein where the peptides will be released by protease treatment with trypsin during sample preparation.
The synthetic protein comprises of 2 reference peptides for the SARS-CoV-2 Spike protein, 15 reference peptides for the (highly expressed) nuclear capsid protein (NCAP), control peptides for histone H2A, H2B, H3 and H4 to determine sample quality and synthetic peptides for workflow calibration and standardisation by our complementary product RePLiCAL.
Van Puyvelde et al.: Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients
- Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients. Van Puyvelde B, et al., JACS Au 2021 Jun 28;1(6):750-765. [PubMed]
- Cov2MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein. van Puyvelde B, et al., Anal. Chem. 2022, 94, 50, 17379–17387 [PubMed]
- A fast and sensitive absolute quantification assay for the detection of SARS-CoV-2 peptides using parallel reaction monitoring mass spectrometry. Gajbhiye A et al., J Proteomics. 2022 Aug 15;265:104664. [PubMed]
Whitepaper and application notes
Mass spectrometry-based Detection of SARS-CoV-2 Infection
In this whitepaper we describe the development of Cov-MS for detection of SARS-CoV-2 infection in nasopharyngeal swabs and its suitability in clinical assays.
Our prices are net prices, i.e. they do not contain value added taxes or customs fees. These taxes have to be paid by the customer.
Our products are usually shipped 1-2 business days after receiving the order.
Shipment costs depend on destination and packaging (either on dry ice or ambient temperature shipping).
For questions please contact us.